Quantitative proteomic analysis of histone modifications in decitabine sensitive and resistant leukemia cell lines
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1559-0275
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Quantitative proteomic analysis of histone modifications in decitabine sensitive and resistant leukemia cell lines ; volume:13 ; number:1 ; day:5 ; month:7 ; year:2016 ; pages:1-11 ; date:12.2016
Clinical proteomics ; 13, Heft 1 (5.7.2016), 1-11, 12.2016
- Classification
-
Biowissenschaften, Biologie
- Creator
-
Zhang, Chunchao
- Contributor
-
Suo, Jinfeng
Katayama, Hiroyuki
Wei, Yue
Garcia-Manero, Guillermo
Hanash, Samir
SpringerLink (Online service)
- DOI
-
10.1186/s12014-016-9115-z
- URN
-
urn:nbn:de:101:1-2018071018454974003093
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zhang, Chunchao
- Suo, Jinfeng
- Katayama, Hiroyuki
- Wei, Yue
- Garcia-Manero, Guillermo
- Hanash, Samir
- SpringerLink (Online service)
Other Objects (12)
Dynamics of histone modifications
Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis
Functional characterization of histone modifications : survey of novel histone modifications reveals PCMT1 as a new histone methyltransferase
An interactive mass spectrometry atlas of histone posttranslational modifications in T-cell acute leukemia
Histone modifications during cerebral cortex development
Histone modifications and traditional Chinese medicinals
Histone modifications in DNA damage response
Histone Modifications in Acute Kidney Injury
DeepHistone: a deep learning approach to predicting histone modifications
Functions of histone modifications and histone modifiers in Schwann cells
Epigenetic therapy of acute myeloid leukemia using 5-aza-2'-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation
Detection of histone modifications in plant leaves
Dynamics of histone modifications
Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis
Functional characterization of histone modifications : survey of novel histone modifications reveals PCMT1 as a new histone methyltransferase
An interactive mass spectrometry atlas of histone posttranslational modifications in T-cell acute leukemia
Histone modifications during cerebral cortex development
Histone modifications and traditional Chinese medicinals
Histone modifications in DNA damage response
Histone Modifications in Acute Kidney Injury
DeepHistone: a deep learning approach to predicting histone modifications
Functions of histone modifications and histone modifiers in Schwann cells
Epigenetic therapy of acute myeloid leukemia using 5-aza-2'-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation
Detection of histone modifications in plant leaves
Dynamics of histone modifications
Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis
Functional characterization of histone modifications : survey of novel histone modifications reveals PCMT1 as a new histone methyltransferase
An interactive mass spectrometry atlas of histone posttranslational modifications in T-cell acute leukemia
Histone modifications during cerebral cortex development
Histone modifications and traditional Chinese medicinals
Histone modifications in DNA damage response
Histone Modifications in Acute Kidney Injury
DeepHistone: a deep learning approach to predicting histone modifications
Functions of histone modifications and histone modifiers in Schwann cells
Epigenetic therapy of acute myeloid leukemia using 5-aza-2'-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation